Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VHL | P40337 | 18/20 | 0.56 |
| ▸ | SMARCA2 | P51531 | 4/20 | 0.53 |
| ▸ | SMARCA4 | P51532 | 4/20 | 0.53 |
| ▸ | ELOC | Q15369 | 2/20 | 0.38 |
| ▸ | ELOB | Q15370 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31589099 | 1.00 | VHL (0.56) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL26804537 | 0.93 | VHL (0.58) | VHLSMARCA2SMARCA4 | |
| SCHEMBL26653883 | 0.91 | VHL (0.43) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL26653886 | 0.91 | VHL (0.43) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL26794220 | 0.87 | VHL (0.56) | VHLSMARCA2SMARCA4 | |
| SCHEMBL31294097 | 0.86 | VHL (0.58) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL31294108 | 0.86 | VHL (0.62) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL31294105 | 0.86 | VHL (0.62) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL30666227 | 0.86 | VHL (0.59) | VHLSMARCA2SMARCA4ELOCELOB | |
| SCHEMBL30666268 | 0.86 | VHL (0.59) | VHLSMARCA2SMARCA4ELOCELOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4522279-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | Foghorn Therapeutics Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| WO-2023220134-A1 | PYRAZINE DERIVATIVES AND USES THEREOF | FOGHORN THERAPEUTICS INC. (US) | 2023-11-16 | — | — | WO | disclosed |